BioSpace News Archive

Press Releases

Vetter Recognized as 2026 CDMO Leadership Awards Winner

Independent recognition strengthens Vetter’s position as a trusted, high-performing CDMO • Awards recognize CDMO performance in five categories • Selection is based on quantitative metrics and verified sponsor feedback from biopharma partners • Recognition reflects trust placed in Vetter by industry and customers

March 30, 2026
·
1 min read
Press Releases

SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update

March 30, 2026
·
17 min read
Press Releases

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

March 30, 2026
·
12 min read
Press Releases

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 30, 2026
·
7 min read
Press Releases

Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement

March 30, 2026
·
6 min read
Press Releases

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

March 30, 2026
·
18 min read
Press Releases

Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress

March 30, 2026
·
5 min read
Press Releases

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 30, 2026

March 30, 2026
·
2 min read
Press Releases

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

March 30, 2026
·
7 min read
Press Releases

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

March 30, 2026
·
11 min read